Predictive nomogram for coronary heart disease in patients with type 2 diabetes mellitus

被引:6
|
作者
Xiao, Shucai [1 ]
Dong, Youzheng [1 ]
Huang, Bin [1 ]
Jiang, Xinghua [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang, Peoples R China
来源
关键词
prediction model; nomogram; coronary heart disease; type 2 diabetes mellitus; coronary angiography; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; ATHEROGENIC INDEX; APOLIPOPROTEIN-B; LDL CHOLESTEROL; HDL CHOLESTEROL; ARTERY; ATHEROSCLEROSIS; ASSOCIATION; LIPOPROTEIN;
D O I
10.3389/fcvm.2022.1052547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study aimed to identify risk factors for coronary heart disease (CHD) in patients with type 2 diabetes mellitus (T2DM), build a clinical prediction model, and draw a nomogram. Study design and methodsCoronary angiography was performed for 1,808 diabetic patients who were recruited at the department of cardiology in The Second Affiliated Hospital of Nanchang University from June 2020 to June 2022. After applying exclusion criteria, 560 patients were finally enrolled in this study and randomly divided into training cohorts (n = 392) and validation cohorts (n = 168). The least absolute shrinkage and selection operator (LASSO) is used to filter features in the training dataset. Finally, we use logical regression to establish a prediction model for the selected features and draw a nomogram. ResultsThe discrimination, calibration, and clinical usefulness of the prediction model were evaluated using the c-index, receiver operating characteristic (ROC) curve, calibration chart, and decision curve. The effects of gender, diabetes duration, non-high-density lipoprotein cholesterol, apolipoprotein A1, lipoprotein (a), homocysteine, atherogenic index of plasma (AIP), nerve conduction velocity, and carotid plaque merit further study. The C-index was 0.803 (0.759-0.847) in the training cohort and 0.775 (0.705-0.845) in the validation cohort. In the ROC curve, the Area Under Curve (AUC) of the training set is 0.802, and the AUC of the validation set is 0.753. The calibration curve showed no overfitting of the model. The decision curve analysis (DCA) demonstrated that the nomogram is effective in clinical practice. ConclusionBased on clinical information, we established a prediction model for CHD in patients with T2DM.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Therapy of Type 2 Diabetes Mellitus in Patients with Heart Disease
    Kerner, W.
    Motz, W.
    AKTUELLE KARDIOLOGIE, 2013, 2 (01) : 17 - 23
  • [22] Incidence and risks of coronary heart disease and heart failure in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry
    Iwase, Masanori
    Ohkuma, Toshiaki
    Fujii, Hiroki
    Oku, Yutaro
    Higashi, Taiki
    Oshiro, Ayaka
    Ide, Hitoshi
    Nakamura, Udai
    Kitazono, Takanari
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 201
  • [23] Treatment of coronary heart disease in patients with diabetes mellitus
    Gradaus, F
    Leschke, M
    Jax, TW
    Schannwell, CM
    Schoebel, FC
    Strauer, BE
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 123 (47) : 1419 - 1425
  • [24] Severity and Outcome of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus and in Patients with Coronary Heart Disease
    Tziomalos, Konstantinos
    Bouziana, Stella
    Spanou, Marianna
    Kostaki, Stavroula
    Papadopoulou, Maria
    Poulou, Stella-Maria Angelo
    Tsopozidi, Maria
    Giampatzis, Vasilios
    Savopoulos, Christos
    Hatzitolios, Apostolos I.
    DIABETES, 2016, 65 : A115 - A115
  • [25] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [26] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    Acta Diabetologica, 2003, 40 : 176 - 180
  • [27] Management of coronary artery disease in patients with type 2 diabetes mellitus
    Srikanth S.
    Deedwania P.
    Current Cardiology Reports, 2007, 9 (4) : 264 - 271
  • [28] The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease
    Farrokhian, Alireza
    Mahmoodian, Mina
    Bahmani, Fereshteh
    Amirani, Elaheh
    Shafabakhsh, Rana
    Asemi, Zatollah
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 194 (02) : 313 - 320
  • [29] A supervised learning approach to predicting coronary heart disease complications in type 2 diabetes mellitus patients
    Giardina, Marisol
    Azuaje, Francisco
    McCullagh, Paul
    Harper, Roy
    BIBE 2006: SIXTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, 2006, : 325 - +
  • [30] TYPE 2 DIABETES MELLITUS IS ASSOCIATED WITH CAROTID ARTERY PLAQUES IN PATIENTS WITH PREMATURE CORONARY HEART DISEASE
    Gabriel Juarez-Rojas, J.
    Posadas-Romero, Carlos
    Martinez-Alvarado, Rocio
    Jorge-Galarza, Esteban
    Reyes-Barrera, Juan
    Gabriela Sanchez-Lozada, L.
    Torres-Tamayo, Margarita
    Medina-Urrutia, Aida X.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (06): : 301 - 309